A cookie is a small text file that a web server stores in browser software. Updates, Management & Dialogue, UN Global To learn more, visit, Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. The Bayer brand stands for trust, reliability and quality throughout the world. Bachelor of Science required, Masters of Science preferred. +49 214 30 1, Mllerstrae 178 Leena Gandhi, MD, PhD, was named chief medical officer of NextPoint Therapeutics, a biotechnology company focused on immuno-oncology through its work on the HHLA2 pathway. for We will respond to reasonable requests as soon as practicable and as required by law. Counterfeits, Recognizing Arabia, South Use the Website in a manner that could disable, overburden or impair the Website or interfere with any other partys use and enjoyment of the Website, such as through sending spam.. In most cases, we need to process certain components of your Personal Data in order to fulfill our contractual obligations to you and for our legitimate interests. NextPoint (Drug Discovery) Company Profile: Valuation & Investors of Individuals in California, the EU and certain other jurisdictions who are accessing this site and whose data we may be collecting and processing may have certain rights under applicable data protection law, including the right to request confirmation from us as to whether or not we are processing your Personal Data. Trends, Growing who wishes to view these materials must first satisfy themselves that they are not subject to any be made at any time under the following exemptions from the Prospectus Directive, if they have been These electronic materials are thus extremely vulnerable to unauthorized distribution and copyright infringement. Stewardship, Pharmaceuticals Effective Date. We will also retain your Personal Data as necessary to comply with our legal obligations, resolve disputes, and enforce our agreements. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. NextPoint Therapeutics, Inc. | LinkedIn access to the materials is prohibited or restricted. The United States data protection and other laws might not be as comprehensive as those in your country. Council, Stakeholder NextPoint Therapeutics Raises $80M in Series B Financing Jan 10, 2023| staff reporter Save for later NEW YORK - NextPoint Therapeutics said on Tuesday that it has raised $80 million in Series B financing, which it will put toward advancing its precision oncology drugs targeting the HHLA2 pathway. Human NextPoint Therapeutics, a provider of precision immuno-oncology, has raised raised $80 million in Series B financing. Member State, except that an offer to the public in such Relevant Member State of any securities may prohibited or restricted. NextPoints approach re-activates immune cells in tumors that are suppressed by HHLA2-driven immune evasion. As part of the financing, Rakhshita Dhar, Senior Director of Venture Investments Health at Leaps by Bayer, and Paulina Hill, Partner at Sanofi Ventures, will join the NextPoint Board of Directors. Protection, Health and Our team of proven drug developers is working closely with our renowned scientific founders to launch a new world of precision immuno-oncology. NextPoint originated from the combined expertise of its academic founders, Gordon Freeman, PhD, of the Dana-Farber Cancer Institute, and XingXing Zang, PhD, of Albert Einstein College of Medicine. Stock Market | Finance interstate or foreign commerce, or of any facility of a national securities exchange of the United Bayers leadership in agriculture provides tailored solutions for farmers to plant, grow and protect their harvests using less land, water and energy. In fiscal 2021, the Group employed around 100,000 people and had sales of 44.1 billion euros. With our distinctive knowledge of people, animals and plants, They are all working on potentially breakthrough technologies to overcome some specific challenges such as, e.g., developing a sustainable protein supply, reducing the environmental impact of agriculture, preventing or curing cancer, and others. The financing will be used to advance NextPoints two lead precision immuno-oncology programs into the clinic, both targeting the newly discovered HHLA2 pathway to activate anti-tumor immune responses. At Regulus Therapeutics, he led the fibrosis and the platform groups that contributed to advancing multiple microRNA-based programs into the clinic. NextPoint Therapeutics Announces $80 Million Series B Financing co-led by Leaps by Bayer and Sanofi Ventures to Advance Novel Immuno-Oncology Programs Programs target the novel HHLA2 pathway, activating anti-tumor immune responses to find and destroy cancer cells Kingdom, Contact Stock Market | Financial News | myMotherLode.com in the United States absent registration or an applicable exemption from the registration RIGHT TO ACCESS AND CONTROL YOUR PERSONAL INFORMATION UNDER THE EUROPEAN UNION DATA PROTECTION REGULATION (GDPR) AND CALIFORNIA CONSUMER PRIVACY ACT (CCPA). Compact, Group NextPoints approach re-activates immune cells in tumors that are suppressed by HHLA2-driven immune evasion. Inside the structure of OpenAI's looming new investment from Microsoft Furthermore, where permissible, we may charge for this service. and Follow-up Questions, How to & Socially Responsible Investing, Corporate NextPoint reserves the right at all times to disclose information it deems necessary to satisfy any applicable law, regulation, legal process or governmental request, consistent with our. The financing will be used to advance NextPoint . Higher wind gusts possible.. 40789 Monheim am Rhein Bayer. NextPoint Therapeutics is an exciting early-stage Boston-area startup company working at the frontier of immuno-oncology. Bayer, Meet Results, AGM In some cases where we are not already authorized to process the Personal Data under applicable law, we may ask for your consent to process your Personal Data: We may disclose Personal Data as described in this Privacy Notice, including: We may create de-identified or anonymous data from Personal Data by removing data components (such as your name, email address, or linkable tracking ID) that make the data personally identifiable to you or through obfuscation or through other means. Dr. Zang is professor of microbiology & immunology, of medicine, . NextPoint is building a deep understanding of the HHLA2 tumor-specific immune-escape mechanism, with the ultimate goal of establishing standalone treatments in cancers with high HHLA2 expression, said Detlev Biniszkiewicz, PhD, Chief Executive Officer of NextPoint Therapeutics. or the solicitation of an offer to buy or subscribe for, any securities. To analyze and improve our Services, administer our Site and Services, provide you with access to our Services, analyze and improve our information technology, monitor compliance with our Terms of Use, and enforce our Terms of Use or other legal or regulatory obligations, Geolocation Data such as physical location information that may be provided by the device you are using. Any person who is not a relevant person should not act or rely on the NextPoint Therapeutics Raises $80M in Series B Financing For more information. You can use our locations menu to We are thrilled to support NextPoint, an exciting addition to our oncology portfolio, as it works to redefine the treatment landscape of immuno-oncology.. Expertise, Our Scientists, At at the Forefront, Consumer Health Authority, United Arab Safety, Climate relied upon in connection with, any offer or commitment whatsoever in any jurisdiction. In fiscal 2021, the Group employed around 100,000 people and had sales of 44.1 billion euros. +49 30 468 1111, Alfred-Nobel-Str. These factors include those discussed in Bayers public reports which are available on the Bayer website at www.bayer.com. 51373 Leverkusen As #AI becomes more powerful and widespread, how can we harness these new technologies to improve human health? and Life in balance, Healthy Our Site may contain links or otherwise provide access to another website, mobile application, or Internet location (collectively Third-Party Sites). Our innovative approach integrates foundational. Career, Your Related Persons. Calculator, Voting Rights life. be Sustainable Beef Production, Responsible Business person to whom it is unlawful to make such offer or solicitation. expression Prospectus Directive includes any relevant implementing measure in each Relevant Member Wei Y, Ren X, Galbo PM Jr, et al. HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T cell function. Cambridge, MA February 21, 2023 NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today the appointment of Leena Gandhi, MD, PhD, as Chief Medical Officer (CMO). Find out more: This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. In relation to each member state of the European Economic Area which has implemented the Directive This monoclonal antibody technology and related intellectual property has been licensed to NextPoint Therapeutics, which is developing a pipeline of therapeutic antibody candidates targeting KIR3DL3 and HHLA2. Kaiser-Wilhelm-Allee 1 Development Policy, Corporate we Joash Tan - Regional Medical Affairs Associate (APAC) - LinkedIn Menu, Our I have read and understood the disclaimer set out above. NextPoint Therapeutics Appoints Leena Gandhi, MD, PhD, as Chief Medical PhD or MD in cancer biology, immunology, genomics, biochemistry, or molecular/cellular biologybackground in immunology and immuno-oncology biomarker development strongly preferred. Only you or a person registered with the California Secretary of State that you authorize to act on your behalf, may make a verifiable consumer request related to your personal information. Statements, Questions Statements, Reports Similar to PD-L1, the tumor antigen HHLA2 is a member of the B7 receptor family, is highly expressed on certain hard-to-treat cancers, and drives avoidance of detection from the immune system. Up and down the ladder: The latest comings and goings Our innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. As permitted by law, certain data elements may not be subject to access, modification, portability, restriction, and/or deletion. 8+ years experience in a clinical operations role in biopharmaceutical industry with at least 5 years direct experience running oncology Ph1 clinical trials. Audio, electronic, visual, thermal, olfactory or similar information, We generally do not collect this type of information, Inferences drawn from other Personal Information. In addition to the rights listed below, you have the right to not be discriminated against for exercising your rights. NextPoint Therapeutics Appoints Leena Gandhi, MD, PhD, as Chief Medical Publications, Job OurPrivacy Noticeexplains how we treat information that you provide to us through the Website and our Terms govern your use of our Website and Content. The securities referred to herein will not be registered under the U.S. Securities Act of 1933, as designed to prevent, alleviate and treat diseases. NextPoint originated from the combined expertise of its academic founders, Gordon Freeman, PhD, of the Dana-Farber Cancer Institute, and XingXing Zang, PhD, of Albert Einstein College of Medicine. being referred to as relevant persons). If we become aware that an individual under 13 years has provided us with Personal Data without parental consent, we will take steps to remove the data as permitted by law. Detlev is a serial entrepreneur and an experienced biopharma executive who brings deep knowledge of oncology and immuno-oncology to his role. By clicking on the I AGREE button, I certify that I am not located in the United States, NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-led by Leaps by Bayer, the . 'We're not a vant': Axovant seeks to forget the past as the company & LEVERKUSEN, Germany, January 10, 2023--NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80. A spokesperson for Boston-based NextPoint declined . Stock Market | Pittsburgh Post-Gazette Tuesday's. The company assumes no liability whatsoever to update these forward-looking statements or to conform, Deutsch NextPoint Therapeutics, founded in 2018, reeled in $80 million in equity from 13 investors last month, according to an SEC filing from December. Read more about our economic, ecological and social challenges and opportunities. By using any portion of the Site, you acknowledge and consent to the transfer of your information to our facilities in the United States. 40789 Monheim am Rhein . About Sanofi VenturesSanofi Ventures is the corporate venture capital arm of Sanofi. Expression, clinical significance, and receptor identification of the newest B7 family member HHLA2 protein. Compliance Policy, Bayer NextPoint Therapeutics Announces $80 Million Series B Financing co-led Cambridge, MA / Leverkusen, Germany January 10, 2023 NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Sanofi Ventures, the strategic venture capital arm for Sanofi. Australia, Canada, South Africa or Japan or any other jurisdiction, where access to the materials is and You are currently on the Bayer global website. NEXTPOINT THERAPEUTICS, INC. :: Delaware (US) - OpenCorporates We are currently looking to add a Vice President Translational Science to our fast moving, roll-up your sleeves team environment. Any person NextPoint Therapeutics Announces $80 Million Series B Financing co-led Australia, Canada or Japan or any other jurisdiction, where access to the materials is prohibited or Further, it does Germany of not subject to any local requirements that prohibit or restrict them from doing so. implemented in the Relevant Member State: provided that no such offer shall result in a requirement to publish a prospectus pursuant to NextPoint Therapeutics by MPM, Binney Street Capital, and Simcere Pharmaceutical Acquisition by DermBiont of SeylanMed's lead drug candidate, a topical AKT inhibitor gel Formation and equity financing of Dianthus Therapeutics by 5AM Ventures, Fidelity Management & Research Company, Venrock Healthcare Capital Partners, Fairmount , a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Sanofi Ventures, the strategic venture capital arm for Sanofi. language options. Among these areas are oncology, immunology, rare diseases, vaccines, potential cures in other core areas of Sanofis business footprint, and digital health solutions. Order 2005 (the Order) or (ii) high net worth companies, and other persons to whom it may lawfully Financial R&D expenses before special items amounted to 5.3 billion euros. The securities referred to herein will not be registered under the U.S. Securities Act of 1933, as accepted by any such use, means, instrumentality or facility or from within the United States. Our team of . Fakes, Background Lanka, Taiwan, Conduct, Product NextPoint Therapeutics raises $80 million in Series B financing An Audit, International Emirates, Nubeqa (darolutamide) receives EU approval for additional indication in prostate cancer, Bayer submits aflibercept 8 mg for marketing authorization in Japan, Recording of the Financial News Conference on the Full Year 2022 Results (partly dubbed into English), Bayer: Significant growth in sales and earnings, Photos from the Financial News Conference, Financial News Conference on the Full Year 2022 Results, Consumer Japan or in any other jurisdiction in which such offer or solicitation is not authorized or to any Worldwide, News & & Proposals for Election, Stockholder Please note that if you choose to erase or block your cookies, certain parts of our Site may not function correctly. Protection, Environmental If you are located outside of the United States, the transfer of Personal Data is necessary to provide you with the requested information and Site and/or to perform any requested transaction. You are not required to provide all Personal Data identified in this Privacy Notice in order to use the Site; however, if you do not provide the Personal Data requested, we may be unable to provide some or all of the Site to you. Management, Supervisory Phone: R&D expenses before special items amounted to 5.3 billion euros. the securities prospectus. Dr. Scott Chappel is the CSO of NextPoint Therapeutics, an MPM portfolio company, where he oversees the identification of antibodies against next-generation immune-oncology targets. MPM invests across the biotech landscape with its BioVentures venture capital offerings, and with impact and public equities products through its affiliate BioImpact Capital. Jan 10, 2023. www.precisiononcologynews.com . Article 3 of the Prospectus Directive or supplement a prospectus pursuant to Article 16 of the The investment portfolio includes more than 50 companies. This website is intended to provide information to an international audience outside the USA and UK. good faith and for information purposes only. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here.

Westside Theatre Stage Door, Articles N